Updated Monkeypox Treatment Guidance and Other Key Resources

Advisory Alert

July 12, 2022

*Cette information est seulement disponible en anglais.

To: Local Health System Partners


Stay up-to-date with Monkeypox testing and treatment guidance and other key resources by visiting the Ministry of Health website

Tecovirimat (TPoxx®) is an antiviral medication used to treat monkeypox infection. There is a very limited supply in Ontario and currently it is indicated for treatment of severely ill patients or those at high risk for severe disease. Further information can be found in the Ministry of Health Monkeypox Antiviral Guidance for Health Care Providers and Antiviral Information Sheet.

Clinicians can stay up-to-date by visiting the Ministry of Health’s Monkeypox Virus Emergency Planning and Preparedness website.

Patients presenting with risk factors and signs and symptoms compatible with infection should be tested in accordance with current monkeypox testing guidance. Other viral illness such as chickenpox and hand foot and mouth disease should be considered in the differential diagnosis. Refer to the attached quick reference guide comparing these viruses with links to testing information.

Please be reminded that persons under investigation, suspected, probable, and confirmed cases of monkeypox virus are reportable to the local Medical Officer of Health. Please complete the first four pages of the Ontario Monkeypox Investigation Tool and fax to Public Health Sudbury & Districts confidential fax at 1.705.677.9618.

For further information, please contact the Control of Infectious Diseases program at 705.522.9200, ext. 772 (toll-free 1.866.522.9200).


Original Signed By

Dr. Penny Sutcliffe
Medical Officer of Health and Chief Executive Officer

NOTE: All Advisory Alerts are found on our website.

This item was last modified on July 12, 2022